Sandoz Group AG (SDZ.SW)

CHF 33.0

(-7.15%)

Market Cap (In CHF)

14.21 Billion

Revenue (In CHF)

9.97 Billion

Net Income (In CHF)

77 Million

Avg. Volume

1.2 Million

Currency
CHF
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
25.33-41.16
PE
-1650.0
EPS
-0.02
Beta Value
2.6227152
ISIN
CH1243598427
CUSIP
-
CIK
-
Shares
430700000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Richard Saynor
Employee Count
-
Website
https://www.sandoz.com
Ipo Date
2023-10-03
Details
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.